A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Completed · Phase 4

Conditions studied: Migraine

In brief

The main purpose of this study is to evaluate the effect of erenumab on medication-specific treatment satisfaction.

Key facts

Study ID

NCT04825678

Run by

Amgen

People needed

240

Starts

2021-06-11

Expected to finish

2023-09-28

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Participant has provided informed consent
• History of migraine (with or without aura) for ≥ 12 months before screening
• ≥ 4 migraine days per month on average across the 3 months prior to screening
• Treatment with 1 oral migraine preventive medication and/or concomitant use of OnabotulinumtoxinA injections for migraine prevention.
• Participant reports to their provider intolerance or insufficient response with their current preventative treatment

You may not qualify if…

• History of cluster headache or hemiplegic migraine headache
• Unable to differentiate migraine from other headaches
• Evidence of substance-related disorders
• Active chronic pain syndromes (eg, fibromyalgia and chronic pelvic pain)
• No therapeutic response with > 3 migraine preventive medication categories
• Used a prohibited medication, device, or procedure
• Other clinically significant disorder, condition, or disease

Where it is running

• Rehabilitation and Neurological Services LLC — Huntsville, Alabama, United States
• Elite Clinical Studies LLC — Phoenix, Arizona, United States
• Neurology Center of North Orange County — Fullerton, California, United States
• The Neurology Group — Pomona, California, United States
• Mountain Neurological Research Center — Basalt, Colorado, United States
• Mindscapes Counseling, LLC — Norwich, Connecticut, United States
• Reliable Clinical Research, LLC — Hialeah, Florida, United States
• Homestead Associates In Research Inc — Homestead, Florida, United States
• New Age Medical Research Corporation — Miami, Florida, United States
• The Community Research of South Florida — Miami Lakes, Florida, United States
• Research Institute of Orlando — Orlando, Florida, United States
• Pas Research — Tampa, Florida, United States
• Georgia Institute for Clinical Research, LLC — Marietta, Georgia, United States
• Chicago Headache Center and Research Institute — Chicago, Illinois, United States
• College Park Family Care Center — Overland Park, Kansas, United States
• Family HealthCare — Germantown, Maryland, United States
• Neurology Center of New England — Foxborough, Massachusetts, United States
• ActivMed Practices and Research, LLC — Lowell, Massachusetts, United States
• Memorial Healthcare Foundation — Owosso, Michigan, United States
• SRI International — Plymouth, Michigan, United States
• Citizens Memorial Healthcare — Bolivar, Missouri, United States
• Clinvest Research LLC — Springfield, Missouri, United States
• Psych Care Consultants — St Louis, Missouri, United States
• Albuquerque Clinical Trials Inc — Albuquerque, New Mexico, United States
• Albany Medical College — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.